| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07015242 A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… |
Trial sites reduced: 82 -> 40 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-02 | NCT07621497 FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07412613 | Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch… | Resectable Colon Cancer | Recruiting |
| Phase 2 | |||
| NCT07015242 | A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… | Lymphoma | Recruiting |
| NCT04245865 | Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer | Colorectal Cancer Metastatic | Active, Not Recruiting |
| NCT07441369 | Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal… | Liver Metastases From Colorectal Cancer (mCRC) | Enrolling by Invitation |
| NCT06094140 | NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer | Pancreatic Cancer | Active, Not Recruiting |
| NCT07621497 | FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable… | Metastatic Colorectal Cancer (CRC) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07056777 | Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard… | Gastrointestinal Cancer | Recruiting |
| NCT05846867 | A Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS… | Colorectal Cancer | Active, Not Recruiting |
| Phase 1 | |||
| NCT07543744 | A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and… | Metastatic Colorectal Cancer | Recruiting |
| NCT06544655 | A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid… | Advanced Solid Tumors | Active, Not Recruiting |